Tesamorelin
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). In research models it binds pituitary GHRH receptors and stimulates the pulsatile release of endogenous growth hormone, which in turn raises circulating IGF-1. Because it acts upstream on the body's own secretory pathway rather than delivering growth hormone directly, it is widely used as a model compound to study the GHRH–GH–IGF-1 axis and the regulation of visceral adipose tissue.
- 01GHRH receptor signaling in the pituitary
- 02Pulsatile growth hormone release
- 03IGF-1 axis regulation
- 04Visceral adipose tissue metabolism
- 05Lipid-profile and metabolic studies
- PURITY
- >99% (HPLC verified)
- FORMAT
- Lyophilized powder
- QUANTITY
- 10 mg per vial
- STORAGE
- 2–8°C
- HANDLING
- Laboratory research use only
Its GHRH-analog mechanism is distinct from administering growth hormone directly, which is why the scientific literature studying tesamorelin monitors IGF-1, glucose and fluid balance. Preclinical and clinical research has focused on reductions in visceral adipose tissue and associated changes in lipid markers; these findings come from defined study populations and the compound is supplied strictly for laboratory research.
